A platform for dialogue

As a step towards connecting the life science industry in Denmark, Biologue was founded three years ago with 10 member companies. Today, the network has 40 memb...

Apoteket gets new vice CEO

The Swedish government company Apoteket has recently appointed a vice CEO.

Orexo mot nya marknader

Smärtbehandlingen Abstral har godkänts för försäljning i Frankrike och Spanien. Det ger Orexo rätt till en milstolpeutbetalning.

Life science in Stockholm

Sweden has the fourth-largest biotech market in Europe. More than half of its biotechnology enterprise, some 460 companies, is located in the Stockholm region.

Tre Nobelpristagare berättar om sin resa på Esof 2012

Esof 2012 i Dublin. Jules Hoffmann (2011), James Watson (1962) och Peter Doherty (1996) berättar om forskningen som ledde till ett Nobelpris.

Go ahead for leg wound study

Tripep starts a phase II-study of their wound healing joint venture project.

Recipharm launches into biologics manufacturing

Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.

EUR 2 million for peanut allergies

ALK Abelló has signed an agreement to invest EUR 2 million in the French biotechnology company DBV Technologies.

Think outside the... brain

Riitta Hari from the Brain Research Unit at the Helsinki University of Technology has recently stated that the mind is more than just the brain.

Swiss allergy therapy convinces

Cytos Biotechnology presents promising results in a study of a new therapy against allergy and asthma.

Tikomed får särläkemedelsstatus

EU:s kommitté för särläkemedel har beviljat särläkemedelsstatus för preparatet Ibsolvmir. Substansen utvecklas för att förhindra avstötning vid transplantation ...

Biotage is regrouping

The Swedish company Biotage takes yet another step in streamlining efforts, by outsourcing all instrument production to contract manufacturers.

Medicult disclaims Swedish offer

The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.

Meda gets access to Asia

The biotech giant Meda has recently acquires world-wide rights to the cancer breakthrough pain drug Onsolis.

Biotech goes white and bright

White biotech could become Denmark's next blossoming business area.

Young, bright and committed to labtech

Ghazal Voghoui recently bought her first apartment and finally settled in Stockholm again. Last year, she finished her law studies and she is relieved to be bac...

Vart tog ljuset i tunneln vägen?

Det är mycket svårt att utveckla läkemedel mot de stora volymsjukdomarna

Ny och vassare mjukvara från CLC Bio

Danska CLC Bio har byggt ut sin mjukvaruplattform för genomisk analys med nytt stöd för både mikroarraybaserade och digitala genuttrycksmätningar samt extra sna...

EU says yes to Roche drug

EU approves a first in class therapy for treatment of patients with moderate to severe form of rheumatoid arthritis.

Bio engineering breakthrough in Denmark

Brand new research makes BioGasol's cellulosic ethanol process even more competitive.

Hårdare krav på godkännanden i EU än i USA?

Eli Lilly writes biotech fine history

The American biotech company Eli Lilly will pay US 1.415 billion to resolve allegations of off-label promotion of a dementia drug.

Gamla läkemedel nästa innovation

Det finns tusentals nya användningsområden för redan godkända läkemedel. Dock finns det få affärsmodeller som kan utnyttja detta.

USA influerar ny stiftelse

Nu startar den nya stiftelsen Forska Sverige som, likt sin amerikanska motsvarighet Research America, ska stärka den medicinska forskningen.